Akorn acquisition to close by week end

In a unanimous vote the FTC approves Akorn's (AKRX -2.5%) acquisition of Hi-Tech Pharmacal (HITK +0.3%) after Akorn agreed to divest certain products as a condition of its approval.

The move was first reported in August.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs